CAI vs GIS · rev $812.0M vs P/E 8.2, rev $18.42B
Caris Life Sciences, Inc. Common Stock (CAI) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
CAI currently screens at market cap $5.22B. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the CAI and GIS stock pages for the full models.
Not investment advice.